LEADER 04655nam 22007095 450 001 9910734848103321 005 20230703185029.0 010 $a3-031-32458-7 024 7 $a10.1007/978-3-031-32458-1 035 $a(MiAaPQ)EBC30616879 035 $a(Au-PeEL)EBL30616879 035 $a(DE-He213)978-3-031-32458-1 035 $a(PPN)272254533 035 $a(EXLCZ)9927442514900041 100 $a20230703d2023 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aCancer Research: An Interdisciplinary Approach$b[electronic resource] /$fedited by Nima Rezaei 205 $a1st ed. 2023. 210 1$aCham :$cSpringer Nature Switzerland :$cImprint: Springer,$d2023. 215 $a1 online resource (614 pages) 225 1 $aInterdisciplinary Cancer Research,$x2731-457X ;$v1 311 08$aPrint version: Rezaei, Nima Cancer Research: an Interdisciplinary Approach Cham : Springer,c2023 9783031324574 327 $aInterdisciplinary Approaches in Cancer Research -- Role of Immune Cells in the Tumor Microenvironment -- Spatial Transcriptomic Approaches for Understanding the Tumor Microenvironment (TME) -- Role of Mesenchymal Stem/Stromal Cells in Cancer Development -- Cancer-associated Fibroblasts and Their Role in Cancer Progression -- The Role of Tumoroids in Cancer Research -- Myokines Expression in Cancer Cachexia -- Epigenetics in Cancer Biology -- Epigenetic Regulation of Cancer by Natural Touch: Phytochemicals and Epigenetic Regulation -- Telomerase Reverse Transcriptase in Humans: From Biology to Cancer Immunity -- Molecular Mechanisms of Metal-induced Carcinogenesis -- Epi-drugs Targeting RNA Dynamics in Cancer -- Oncologic Emergencies: Pathophysiology, Diagnosis, and Initial Management -- Malignancies in Inborn Errors of Immunity -- Hematopoietic Stem Cell Transplantation in Patients with Inborn Errors of Immunity and Malignancy -- Personalized Immuno-oncology with Immunodeficiency Mouse Models -- Allergy and Cancer: New Perspectives -- Depression and Cancer: the Inflammatory Bridge -- Impact of Cancer-Related Sarcopenia on Systemic Immune Status -- Surveillance of Subclinical Cardiovascular Complications in Childhood Cancer Survivors: Exercise as a Diagnostic and Therapeutic Modality. 330 $aCancer is a major public health concern and one of the leading causes of death. There is no simple solution for this complex disease, therefore interdisciplinary approaches might help to find solutions to many unanswered questions and challenges about cancer. The rapid flow of interdisciplinary research in cancer during recent years has increased our understanding of the nature of cancers. Such interdisciplinary approaches could be helpful for both the diagnosis and the development of more effective therapeutic strategies. The ?Interdisciplinary Cancer Research? series publishes comprehensive volumes on different cancers and presents the most updated and peer-reviewed articles on human cancers. Over the past decade, increased cancer research has greatly improved our understanding of the nature of cancerous cells which has led to the development of more effective therapeutic strategies to treat cancers. This interdisciplinary series is of special value to researchers and practitioners working on cell biology, immunology, hematology, biochemistry, genetics, oncology and related fields. This is the main concept of Cancer Immunology Project (CIP), which is a part of Universal Scientific Education and Research Network (USERN). 410 0$aInterdisciplinary Cancer Research,$x2731-457X ;$v1 606 $aCancer 606 $aCancer?Treatment 606 $aStem cells 606 $aCytology 606 $aMedical genetics 606 $aImmunology 606 $aCancer Biology 606 $aCancer Therapy 606 $aCancer Stem Cells 606 $aCell Biology 606 $aMedical Genetics 606 $aImmunology 615 0$aCancer. 615 0$aCancer?Treatment. 615 0$aStem cells. 615 0$aCytology. 615 0$aMedical genetics. 615 0$aImmunology. 615 14$aCancer Biology. 615 24$aCancer Therapy. 615 24$aCancer Stem Cells. 615 24$aCell Biology. 615 24$aMedical Genetics. 615 24$aImmunology. 676 $a616.9940072 700 $aRezaei$b Nima$0913363 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910734848103321 996 $aCancer Research: An Interdisciplinary Approach$93577369 997 $aUNINA